```html

Quinolone‑Induced Tendon Rupture: What You Need to Know

Overview

Fluoroquinolones (commonly called quinolones) are a class of broad‑spectrum antibiotics that include drugs such as ciprofloxacin, levofloxacin, and moxifloxacin. While they are highly effective for urinary‑tract infections, respiratory infections, and certain gastrointestinal illnesses, a rare but serious side effect is tendon injury—ranging from tendonitis to complete tendon rupture. This condition is referred to as **quinolone‑induced tendon rupture**.

Who is affected? The risk is highest in adults over 60 years, individuals taking corticosteroids, and patients with pre‑existing tendon disorders. However, cases have been reported in younger, otherwise healthy people, especially after high‑dose or prolonged therapy.

Prevalence: According to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), the incidence of tendon rupture associated with fluoroquinolones is estimated at **0.1–0.4 %** of treated patients, with the Achilles tendon being the most common site.<sup>1,2</sup> Although rare, the consequences can be disabling, prompting regulatory agencies to add boxed warnings to all fluoroquinolone labels.

Symptoms

Symptoms may appear during therapy or up to several months after discontinuation. The classic presentation progresses from mild discomfort to complete rupture.

• Pain or tenderness over the affected tendon, often described as a deep ache that worsens with activity.
• Swelling or warmth around the tendon, occasionally accompanied by bruising.
• Stiffness and reduced range of motion, particularly after periods of rest.
• Grinding or popping sensation (crepitus) when moving the joint.
• Sudden “snap” or “pop” feeling, followed by immediate loss of function—indicative of a complete rupture.
• Weakness in the muscle group that the tendon supports (e.g., inability to plantar‑flex the foot if the Achilles tendon ruptures).
• Visible deformity such as a “gap” in the tendon or a drooping foot/hand.
• Difficulty bearing weight or performing daily activities that rely on the affected tendon.

Causes and Risk Factors

Mechanism of Injury

Fluoroquinolones interfere with collagen synthesis and degrade extracellular matrix proteins. Animal studies suggest that these antibiotics increase matrix‑metalloproteinase activity, leading to weakened tendon fibers and micro‑tears that can progress to full‑thickness rupture, especially under mechanical stress.<sup>3</sup>

Key Risk Factors

• Age ≥ 60 years – age‑related tendon degeneration predisposes to injury.
• Corticosteroid use (oral, inhaled, or intra‑articular) – synergistic weakening of tendon collagen.
• Renal impairment – reduced drug clearance leads to higher systemic exposure.
• Organ transplantation or chemotherapy – immunosuppression and tissue fragility.
• Physical activity – strenuous exercise, especially soon after starting quinolones, raises the mechanical load on vulnerable tendons.
• Pre‑existing tendon disease (tendinopathy, previous rupture, or chronic overuse).
• Female sex – some epidemiologic data show a slightly higher incidence in women, though the reason is unclear.<sup>4</sup>

Diagnosis

Timely diagnosis relies on a combination of clinical suspicion, physical examination, and imaging.

Clinical Evaluation

• History of recent fluoroquinolone use (typically within the past 30 days).
• Physical exam noting tenderness, swelling, and a positive Thompson or Simmonds’ test for Achilles rupture.

Imaging Studies

• Ultrasound – quick, bedside tool to detect tendon thickening, tears, or discontinuity.
• MRI (Magnetic Resonance Imaging) – gold standard for assessing extent of rupture, retraction length, and surrounding edema.
• X‑ray – generally normal for tendon injuries but useful to rule out bony avulsion or fractures.

Laboratory Tests

While no lab test confirms tendon rupture, baseline labs (CBC, renal function) are often obtained to evaluate overall health and guide medication adjustments.

Treatment Options

Management is individualized based on rupture severity, patient age, activity level, and comorbidities.

Immediate Measures

• Discontinue the fluoroquinolone immediately; consider alternative antibiotics (e.g., amoxicillin‑clavulanate, doxycycline) after consulting the prescribing clinician.
• Immobilize the affected limb (e.g., splint, cast, or functional brace) to prevent further fiber disruption.
• Apply ice packs for 15‑20 minutes every 2–3 hours during the first 48 hours to reduce swelling.

Non‑Surgical Management

Appropriate for partial tears, low‑demand patients, or those with high surgical risk.

• Physical therapy – early passive range‑of‑motion, progressing to eccentric strengthening once pain subsides.
• Analgesia – acetaminophen or NSAIDs (if not contraindicated) for pain control.
• Functional bracing – semi‑rigid orthosis allowing controlled motion while protecting the repair.

Surgical Repair

Recommended for complete ruptures, especially in active individuals.

• Open or minimally invasive tendon repair techniques (e.g., Krackow stitch, percutaneous suturing).
• Post‑operative immobilization in a plantar‑flexed position for 2‑3 weeks, followed by graduated weight‑bearing.
• Rehabilitation protocol usually spans 12‑16 weeks, emphasizing progressive loading and proprioception.

Adjunctive Therapies

• Vitamin C & Collagen supplements – limited evidence but may support collagen synthesis.
• Platelet‑rich plasma (PRP) – investigational; some studies suggest improved healing times.

Living with Quinolone‑Induced Tendon Rupture

Recovery can be lengthy, but adherence to a structured plan maximizes outcomes.

• Activity modification – avoid high‑impact sports or heavy lifting for at least 6 months after repair.
• Regular physiotherapy – attend scheduled sessions and perform home exercises as prescribed.
• Maintain a healthy weight – excess body mass increases tendon load.
• Footwear – use supportive shoes with cushioned soles; consider orthotics for Achilles or patellar tendon issues.
• Hydration & nutrition – adequate protein and micronutrients (vitamins C, D, zinc) support tissue repair.
• Medication review – keep an updated list of antibiotics you’ve taken; inform any future prescriber of the previous tendon injury.

Prevention

Because the risk is largely medication‑related, prevention focuses on prudent prescribing and patient education.

• Reserve fluoroquinolones for cases where no safer alternative exists (e.g., multi‑drug‑resistant infections).
• Screen for risk factors before prescribing—check age, corticosteroid use, renal function, and history of tendon disorders.
• Educate patients to stop activity and report tendon pain immediately while on the drug.
• Limit treatment duration to the shortest effective course (often ≤7 days for uncomplicated infections).
• Avoid concomitant corticosteroids unless absolutely necessary; if unavoidable, consider a non‑fluoroquinolone antibiotic.

Complications

If not recognized promptly, tendon rupture can lead to serious sequelae:

• Permanent functional loss – decreased strength, limited range of motion, and difficulty walking or performing daily tasks.
• Chronic pain and development of tendinopathy in adjacent structures.
• Degenerative joint changes due to altered biomechanics.
• Infection of the ruptured tendon (rare but possible, especially after surgery).
• Compensatory injuries – overuse of the contralateral limb may cause sprains or fractures.

When to Seek Emergency Care

References

1. Mayo Clinic. “Fluoroquinolone antibiotics: Risks and side effects.” 2023. mayoclinic.org.
2. U.S. Food and Drug Administration. “FDA Drug Safety Communication: Fluoroquinolone antibiotics associated with disabling side effects.” 2016. fda.gov.
3. Gamsiz G, et al. “Fluoroquinolone‑induced tendon injury: Molecular mechanisms and clinical implications.” *J Orthop Res.* 2021;39(5):1023‑1032.
4. European Medicines Agency. “Review of fluoroquinolone safety data.” 2022. ema.europa.eu.
5. Cleveland Clinic. “Achilles tendon rupture: Diagnosis & treatment.” 2024. clevelandclinic.org.

```